| Net Cash Provided by (Used in) Operating Activities |
$174,836 |
USD |
|
Q4 2024 |
FY 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$1,239,000 |
USD |
|
Q4 2024 |
FY 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$899,669 |
USD |
|
Q4 2024 |
FY 2025 |
| Common Stock, Shares Authorized |
1,000,000,000 |
shares |
0% |
Q4 2025 |
FY 2025 |
| Common Stock, Shares, Issued |
16,716,672 |
shares |
29% |
Q4 2025 |
FY 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q4 2025 |
FY 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$164,495 |
USD |
|
Q4 2024 |
FY 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$1,308,529 |
USD |
669% |
Q4 2025 |
FY 2025 |
| Deferred Tax Assets, Valuation Allowance |
$410,994 |
USD |
|
Q4 2025 |
FY 2025 |
| Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.21 |
pure |
|
Q3 2025 |
Q3 2025 |
| Depreciation |
$50,532 |
USD |
-17% |
Q3 2025 |
Q3 2025 |
| Property, Plant and Equipment, Gross |
$382,237 |
USD |
29% |
Q4 2025 |
FY 2025 |
| Lessee, Operating Lease, Liability, to be Paid, Year One |
$11,624 |
USD |
|
Q4 2025 |
FY 2025 |
| Deferred Income Tax Expense (Benefit) |
$42,546 |
USD |
|
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$551,538 |
USD |
1270% |
Q4 2025 |
FY 2025 |
| Deferred Federal Income Tax Expense (Benefit) |
$35,468 |
USD |
|
Q3 2025 |
Q3 2025 |
| Current Income Tax Expense (Benefit) |
$800 |
USD |
|
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Authorized |
5,000,000 |
shares |
|
Q4 2024 |
FY 2025 |
| Unrecognized Tax Benefits |
$0 |
USD |
|
Q4 2025 |
FY 2025 |
| Additional Paid in Capital |
$15,686,846 |
USD |
831% |
Q4 2025 |
FY 2025 |
| Current State and Local Tax Expense (Benefit) |
$800 |
USD |
|
Q3 2025 |
Q3 2025 |
| Amortization of Intangible Assets |
$9,200 |
USD |
|
Q4 2024 |
FY 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
$140,544 |
USD |
229% |
Q4 2025 |
FY 2025 |
| Deferred State and Local Income Tax Expense (Benefit) |
$7,078 |
USD |
|
Q3 2025 |
Q3 2025 |